Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Oppenheimer Global Opportunities: (MF: OPGIX)

(MF) As of Feb 27, 2015 06:05 PM ET

 Add to portfolio

$41.38 USD

-0.06 (-0.15%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jan 31, 2015

% Yield 0.25
% SEC Yield NA
% YTD Return (as of Jan 31, 2015) -0.25
Objective Global - Equity
Peer GL LG

Zacks Premium Research for OPGIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Sell 4
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 19.54
Net Assets (Mil $) 1/31/2015 2,294.00
%Turnover 1/31/2015 16.00

Allocation

% of Portfolio
Large Growth 14.37
Large Value 0.00
Small Growth 16.13
Small Value 0.00
Foreign Stock 15.48
Emerging Market 0.00
Precious Metal 1.22
Intermediate Bond 0.00
Foreign Bond 21.01
High Yield Bond 13.32

Sector / Country Weightings

As of 1/31/2015 % of Portfolio
United States 55.80
Other 12.99
United Kingdom 6.74
Japan 5.22
Denmark 5.21
Germany 4.80
Finland 2.56
France 2.41
Sweden 1.65
Hong Kong 1.43

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2014)
% of Portfolio Value (Mil$)
NEKTAR THERAPEUTICS 8.85 294.51
ADVANCED MICRO DEVICES IN 2.87 95.48
MORPHOSYS AG 2.65 88.27
NOKIA CORP - ADR 2.56 85.05
YAHOO INC 2.20 73.35
CEPHEID INC 2.12 70.45
IP GROUP 2.03 67.62
NOVOZYMES 1.95 64.95
BOEING CO/THE 1.91 63.69

Stock Holding % of Net Assets

As Of 9/30/2014
Total Issues NA
Avg. P/E 38.74
Avg. P/Book 5.60
Avg. EPS Growth 12.02
Avg. Market Value (Mil $) 14,163

Risk

3 Year 5 Year 10 Year
Beta 1.15 1.12 1.17
Alpha -7.22 -6.57 0.67
R Squared 0.55 0.72 0.74
Std. Dev. 14.39 17.16 20.10
Sharpe 0.84 0.64 2.00